Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer
Condition: Advanced, Persistent, or Recurrent Endometrial CancerInterventions: Drug: Everolimus; Drug: Tamoxifen; Drug: Letrozole; Drug: Medroxyprogesterone AcetateSponsors: Gynecologic Oncology Group; Novartis PharmaceuticalsNot yet recruiting - verified August 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Endometrial Cancer | Hormonal Therapy | Hormones | Research | Tamoxifen